The Biotech Codex is committed to the highest standards of journalistic integrity and editorial independence. Our reporting is driven by facts, scientific evidence, and rigorous analysis.
**Sourcing Standards**
We rely on primary sources whenever possible, including peer-reviewed scientific journals, regulatory filings (such as FDA and EMA documents), company disclosures, and clinical trial data. We prioritize named expert sources, including researchers, clinicians, and industry analysts. Anonymous sources are used only when necessary to protect individuals from retaliation and when the information provided is critical and independently verifiable.
**Separation of News and Opinion**
We maintain a strict separation between our news reporting and opinion or commentary. Opinion pieces, op-eds, and analyses are clearly labeled to distinguish them from factual news reports.
**AI-Assisted Content Disclosure**
As part of OT Media Inc.’s AI-Powered Media Network (AIPMN), The Biotech Codex utilizes artificial intelligence tools to assist in research, data analysis, and initial drafting. However, all content published on our platform is subject to rigorous human editorial review, fact-checking, and final approval. AI tools are used to enhance our capabilities, not replace human judgment.
**Conflict of Interest Disclosure**
Our editors and writers are required to disclose any financial interests or conflicts of interest related to the companies or topics they cover. We do not accept payment or gifts in exchange for news coverage.
**Corrections Policy**
We are committed to accuracy and transparency. When errors occur, we correct them promptly and clearly note the correction within the article.